IPO & Exits Neutral 5

Gaudium IVF IPO: Strong Retail Demand Drives Final Day Bidding Momentum

Gaudium IVF and Women Health's ₹125.22 crore IPO entered its final bidding day with a 3x overall subscription and a steady grey market premium. The offering, consisting entirely of a fresh issue, has seen particularly robust interest from retail investors as the company seeks to expand its fertility clinic network.

· 3 min read · By Startup Intelligence Brief Editorial
Share

Key Takeaways

  • Gaudium IVF and Women Health's ₹125.22 crore IPO entered its final bidding day with a 3x overall subscription and a steady grey market premium.
  • The offering, consisting entirely of a fresh issue, has seen particularly robust interest from retail investors as the company seeks to expand its fertility clinic network.

Mentioned

Gaudium IVF and Women Health company Hem Securities company Kfin Technologies company

Key Intelligence

Key Facts

  1. 1Price band set at ₹236 to ₹248 per share with a lot size of 60 shares
  2. 2Total issue size of ₹125.22 crore consists entirely of a fresh issue of 50.49 lakh shares
  3. 3Retail portion was oversubscribed 4.93x by the end of the second day of bidding
  4. 4Grey Market Premium (GMP) is currently trading at approximately 6.33% over the upper price band
  5. 5Proceeds are earmarked for clinic expansion, equipment upgrades, and debt repayment
  6. 6Hem Securities is acting as the lead manager for the public offering
Retail Investor Sentiment

Analysis

Gaudium IVF and Women Health’s entry into the public markets marks a significant milestone for the specialized healthcare sector in India. As the bidding process reaches its final day, the IPO has demonstrated a clear divide between retail enthusiasm and institutional caution, a common trend in mid-sized healthcare offerings. The company’s decision to structure the ₹125.22 crore issue entirely as a fresh issue of 50.49 lakh shares signals a growth-oriented strategy, with proceeds earmarked for expanding its clinic footprint and upgrading existing infrastructure.

The subscription data from the first two days reveals a strong appetite among individual investors. By the end of Day 2, the retail portion was oversubscribed nearly five times, reflecting a broader market trend where retail participants are increasingly drawn to healthcare and fertility services, which are often viewed as resilient to broader economic volatility. In contrast, the Qualified Institutional Buyer (QIB) segment remained largely quiet during the early stages, a typical pattern where large-scale institutional bids often cluster in the final hours of the third day to assess total demand and market sentiment.

The Grey Market Premium (GMP) has held steady at approximately 6.33%, or roughly ₹15 to ₹16 per share.

From a valuation perspective, the price band of ₹236 to ₹248 per share positions Gaudium IVF as a competitive player in the fertility space. The Grey Market Premium (GMP) has held steady at approximately 6.33%, or roughly ₹15 to ₹16 per share. While this premium is modest compared to some high-flying tech IPOs, it suggests a stable, albeit cautious, optimism regarding the company’s listing performance. Analysts suggest that the steady GMP reflects the company's solid fundamentals but also accounts for the competitive pressures within the fragmented IVF market in India.

What to Watch

The broader context of this IPO is the rapid professionalization and consolidation of the Indian fertility market. As delayed parenthood and increasing awareness drive demand for Assisted Reproductive Technology (ART), startups and established chains like Gaudium are racing to capture market share. The capital infusion from this IPO will likely be used to penetrate Tier-2 and Tier-3 cities, where the demand-supply gap for quality fertility care remains vast. This expansion strategy is critical for Gaudium to achieve the economies of scale necessary to compete with larger, private equity-backed hospital chains.

Looking ahead, the successful listing of Gaudium IVF could serve as a bellwether for other specialized healthcare startups considering the public route. If the stock maintains its premium post-listing, it will validate the specialized healthcare model for investors who are increasingly looking for focused assets rather than diversified conglomerates. Investors will be closely watching the final subscription numbers, particularly the QIB turnout, which will ultimately dictate the listing day momentum and the long-term institutional support for the stock. The allotment is expected to be finalized by February 26, with the official listing scheduled for March 3, 2026.

Timeline

Timeline

  1. Anchor Round

  2. IPO Opens

  3. Final Bidding Day

  4. Basis of Allotment

  5. Stock Listing

Sources

Sources

Based on 1 source article

Cite This Page

"Gaudium IVF IPO: Strong Retail Demand Drives Final Day Bidding Momentum." Startup Intelligence Brief, February 24, 2026. https://getstartupbrief.com/story/gaudium-ivf-ipo-day-3-subscription-analysis

Related Stories

IPO & Exits

SBI Funds’ $12.24B IPO Signals Busy H2 for Indian Startup Exits

The $12.24 billion valuation set by SBI Funds Management in its IPO indicates robust public market appetite for financial services, boding well for upcoming IPOs from Reliance Jio, NSE, and venture-backed startups. We analyze the exit environment and what it means for India's startup ecosystem.

IPO & Exits

DeepSeek Targets $71B Valuation in Pre-IPO Dash After $7B Round

Chinese AI startup DeepSeek is moving at lightning speed: weeks after a $7 billion funding round, it's racing toward an IPO and already pitching a $71 billion valuation for a fresh capital raise. For founders and VCs, this hypergrowth trajectory reveals the extreme stakes and capital intensity of the AI race.

IPO & Exits

SpaceX’s $1.16T Wipeout: 29% Short Float Teaches Founders a Brutal IPO Lesson

The most anticipated IPO of the year has become a cautionary tale: despite a narrative of technological supremacy, public market forces—short sellers, technical setbacks—can obliterate trillions in weeks. Founders re-evaluating exit timelines should study the SPCX selloff closely.

IPO & Exits

BofA’s $520M Loan to OpenAI Heralds AI Mega-IPO Wave for Startups

With a $520 million loan to OpenAI, BofA is not just lending—it’s securing a front-row seat for the coming IPO bonanza. For late-stage AI startups and VCs, this move validates the market for trillion-dollar exits and intensifies competition among banks to back the next generation of AI leaders.

How we covered this story

Every story in our startup coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the startup space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.

Signal on this pageWhat it tells you
Verified by N sourcesIndependent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly.
Impact score (1-10)Regulatory + financial + operational weight. 8+ signals an experienced-operator action item.
SentimentFive-tier classification trained on labeled startup-specific corpora.
TimelineWhere applicable, the related-events sequence that contextualizes today's development.